1. Home
  2. EVO vs GDYN Comparison

EVO vs GDYN Comparison

Compare EVO & GDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • GDYN
  • Stock Information
  • Founded
  • EVO 1993
  • GDYN 2006
  • Country
  • EVO Germany
  • GDYN United States
  • Employees
  • EVO N/A
  • GDYN N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • GDYN Computer Software: Prepackaged Software
  • Sector
  • EVO Health Care
  • GDYN Technology
  • Exchange
  • EVO Nasdaq
  • GDYN Nasdaq
  • Market Cap
  • EVO 1.6B
  • GDYN 1.4B
  • IPO Year
  • EVO 2021
  • GDYN N/A
  • Fundamental
  • Price
  • EVO $4.50
  • GDYN $19.90
  • Analyst Decision
  • EVO Buy
  • GDYN Strong Buy
  • Analyst Count
  • EVO 2
  • GDYN 7
  • Target Price
  • EVO $5.90
  • GDYN $18.14
  • AVG Volume (30 Days)
  • EVO 152.3K
  • GDYN 637.3K
  • Earning Date
  • EVO 11-06-2024
  • GDYN 10-31-2024
  • Dividend Yield
  • EVO N/A
  • GDYN N/A
  • EPS Growth
  • EVO N/A
  • GDYN N/A
  • EPS
  • EVO N/A
  • GDYN 0.03
  • Revenue
  • EVO $866,665,179.00
  • GDYN $328,358,000.00
  • Revenue This Year
  • EVO $4.56
  • GDYN $12.94
  • Revenue Next Year
  • EVO $13.44
  • GDYN $18.35
  • P/E Ratio
  • EVO N/A
  • GDYN $677.19
  • Revenue Growth
  • EVO N/A
  • GDYN 4.10
  • 52 Week Low
  • EVO $2.85
  • GDYN $9.07
  • 52 Week High
  • EVO $12.00
  • GDYN $20.34
  • Technical
  • Relative Strength Index (RSI)
  • EVO 49.65
  • GDYN 63.13
  • Support Level
  • EVO $4.39
  • GDYN $18.82
  • Resistance Level
  • EVO $4.81
  • GDYN $20.15
  • Average True Range (ATR)
  • EVO 0.13
  • GDYN 0.64
  • MACD
  • EVO -0.05
  • GDYN -0.00
  • Stochastic Oscillator
  • EVO 45.24
  • GDYN 79.74

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About GDYN Grid Dynamics Holdings Inc.

Grid Dynamics Holdings Inc provides enterprise-level digital transformation in the areas of search, analytics, and release automation to Fortune 1000 companies. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.

Share on Social Networks: